UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
Filed by the Registrant x
Filed by a Party other than the Registrant ¨
Check the appropriate box:
| ¨ | Preliminary Proxy Statement |
| ¨ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ¨ | Definitive Proxy Statement |
| x | Definitive Additional Materials |
| ¨ | Soliciting Material Pursuant to §240.14a-12 |
Protalix BioTherapeutics, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| x | No fee required. |
| ¨ | Fee paid previously with preliminary materials. |
| ¨ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11 |
| Barcode | ||
| Shareholder Name | ||
| Address 1 | ||
| Address 2 | ||
| Address 3 |
Protalix Biotherapeutics Announces Adjournment of Annual Meeting of Stockholders
Protalix Biotherapeutics. (Ticker: PLX) recently announced that the June 28th, 2023, Annual Meeting is being adjourned until July 13th, 2023, to provide stockholders with additional time to vote on Proposal 5, approval of an amendment to the Company’s Certificate of Incorporation to increase the total number of authorized shares of Common Stock.
Our records indicate your account is currently unvoted.
The Board of Directors as well as leading professional advisory firms ISS and Glass Lewis recommend you FOR Proposal 5.
Proposal 5 requires an affirmative vote of 50% of the outstanding shares for passage. By not responding with your vote, you are essentially opposing this proposal. Therefore, we urge our stockholders who have not yet executed their vote to please do so. This will help save on further solicitation costs and ensure that your important vote is represented.
Please vote your shares of stock now so that your vote can be counted without delay. If you have any questions or require assistance in voting your shares, please contact our proxy solicitor Alliance Advisors toll-free at +1 (855) 200- 7892 or email PLX@AllianceAdvisors.com.
If you wish to vote electronically online you can scan the QR code below:
Insert QR CODE HERE
Sincerely,
Gina Balderas
Operations Manager
| IF YOU HAVE RECENTLY VOTED PLEASE ACCEPT OUR THANKS AND DISREGARD THIS REQUEST. |